The integrity of the scholarly record depends on more than identifying research misconduct, it also depends on what happens when a finding may affect the accuracy, reliability, or interpretation of published work. At that point, institutions and publishers may have different responsibilities, authorities, timelines, and confidentiality and due-process obligations. These differences can create friction and uncertainty about when to communicate, what information can be shared, who should initiate the conversation, and what actions are appropriate to protect the integrity of the published record.

This interactive panel will explore practical strategies for strengthening institution–publisher collaboration before, during, and following research misconduct proceedings. Panelists will examine the respective roles of institutions and publishers; where responsibilities intersect or create friction; and how institutions and publishers can navigate the difficult balance among transparency, confidentiality, fairness, and protection of the research record. The updated HHS Office of Research Integrity framework may affect institutional decision-making regarding disclosure and communication while a research misconduct proceeding is ongoing.

The discussion will consider when early engagement with publishers may be appropriate, what information can and should be communicated at different stages of a proceeding, and how to establish effective communication structures that support timely and appropriate action. Rather than assuming a single party controls the process, the panelists will also explore the respective roles of institutions and publishers in determining whether a published work requires correction, expression of concern, retraction, or another form of record modification.